Reaction
Body Mass Index Increased reporting signals
As of the last recalculation, Body Mass Index Increased appears in 1,320 FAERS reports alongside 36 co-occurring drug terms. The strongest observed disproportionality signal is CICLESONIDE (PRR 25.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ciclesonide | 22 | 25.9 | 25.9 |
| Dutasteride | 10 | 19.5 | 19.6 |
| Lithium | 23 | 14.6 | 14.6 |
| Lithium Bromatum | 23 | 14.6 | 14.6 |
| Fulvestrant | 27 | 13.1 | 13.1 |
| Clozapine | 92 | 12.3 | 12.4 |
| Olanzapine | 71 | 11.0 | 11.0 |
| Dapagliflozin | 21 | 10.7 | 10.7 |
| Zoledronic Acid | 26 | 10.4 | 10.4 |
| Letrozole | 39 | 10.3 | 10.3 |
| Aripiprazole Oral | 26 | 10.1 | 10.1 |
| Aripiprazole Orally Disintegrating | 26 | 10.1 | 10.1 |
| Letrozole Tablets | 30 | 10.0 | 10.0 |
| Amlodipine Besylate And Valsartan | 7 | 10.0 | 10.0 |
| Eplerenone | 8 | 9.9 | 9.9 |
| Oxybutynin Chloride | 5 | 9.0 | 9.0 |
| Umeclidinium | 5 | 8.8 | 8.8 |
| Liraglutide | 27 | 8.8 | 8.8 |
| Palbociclib | 50 | 8.6 | 8.6 |
| Omalizumab | 43 | 8.2 | 8.2 |
| Ziprasidone | 9 | 8.1 | 8.1 |
| Benralizumab | 10 | 7.9 | 7.9 |
| Risperidone | 64 | 7.9 | 7.9 |
| Mometasone Furoate And Formoterol Fumarate Dihydrate | 7 | 7.1 | 7.1 |
| Fingolimod Hcl | 29 | 5.4 | 5.4 |
| Cariprazine | 3 | 5.1 | 5.1 |
| Elexacaftor, Tezacaftor, And Ivacaftor | 4 | 5.1 | 5.1 |
| Crizotinib | 4 | 5.0 | 5.0 |
| Dulaglutide | 27 | 4.9 | 4.9 |
| Etonogestrel | 14 | 4.7 | 4.7 |
| Emtricitabine And Tenofovir Alafenamide | 3 | 4.2 | 4.2 |
| Brexpiprazole | 4 | 3.8 | 3.8 |
| Sacubitril And Valsartan | 25 | 3.4 | 3.4 |
| Ixekizumab | 7 | 3.0 | 3.0 |
| Tirzepatide | 25 | 2.5 | 2.5 |
| Guselkumab | 5 | 2.2 | 2.2 |